Minimally required heat doses for various tumour sizes in induction heating cancer therapy determined by computer simulation using experimental data

References

• Yamada H, Hirano S, Tanaka E, Shichinohe T, Kondo S. Surgical treatment of liver metastases from pancreatic cancer. HPB (Oxford) 2006; 8: 85–88
   PubMedGoogle Scholar
• Fujii M, Miyake H, Sasaki K, Takagi T, Takamura K, Tashiro S. Arterial infusion chemotherapy for the patient of unresectable pancreatic carcinoma with multiple liver metastases: A case report. J Med Invest 2003; 50: 199–202
   PubMedGoogle Scholar
• Katsumata K, Tomioka H, Sumi T, Yamasaki T, Takagi M, Kato F, Suzuki Y, Aoki T, Koyanagi Y. Liver metastasis of pancreatic cancer managed by intra-arterial infusion chemotherapy combined with degradable starch microspheres. Int J Clin Oncol 2003; 8: 110–112
   PubMedGoogle Scholar
• Larson TR, Bostwick DG, Corica A. Temperature-correlated histopathologic changes following microwave thermoablation of obstructive tissue in patients with benign prostatic hyperplasia. Urology 1996; 47: 463–469
   PubMed Web of Science ®Google Scholar
• Timmerman RD, Bizekis CS, Pass HI, Fong Y, Dupuy DE, Dawson LA, Lu D. Local surgical, ablative, and radiation treatment of metastases. CA Cancer J Clin 2009; 59: 145–170
   PubMed Web of Science ®Google Scholar
• Curley SA, Izzo F, Delrio P, Ellis LM, Granchi J, Vallone P, Fiore F, Pignata S, Daniele B, Cremona F. Radiofrequency ablation of unresectable primary and metastatic hepatic malignancies: Results in 123 patients. Ann Surg 1999; 230: 1–8
   PubMed Web of Science ®Google Scholar
• Seki T, Wakabayashi M, Nakagawa T, Itho T, Shiro T, Kunieda K, Sato M, Uchiyama S, Inoue K. Ultrasonically guided percutaneous microwave coagulation therapy for small hepatocellular carcinoma. Cancer 1994; 74: 817–825
   PubMed Web of Science ®Google Scholar
• White TJ, Roy-Choudhury SH, Breen DJ, Cast J, Maraveyas A, Smyth EF, Hartley JE, Monson JR. Percutaneous radiofrequency ablation of colorectal hepatic metastases–initial experience. An adjunct technique to systemic chemotherapy for those with inoperable colorectal hepatic metastases. Dig Surg 2004; 21: 314–320
   PubMed Web of Science ®Google Scholar
• Tranberg KG. Percutaneous ablation of liver tumours. Best Pract Res Clin Gastroenterology 2004; 18: 125–145
   PubMed Web of Science ®Google Scholar
• Jordan A, Wust P, Fahling H, John W, Hinz A, Felix R. Inductive heating of ferrimagnetic particles and magnetic fluids: Physical evaluation of their potential for hyperthermia. Int J Hyperthermia 1993; 9: 51–68
   PubMed Web of Science ®Google Scholar
• Minamimura T, Sato H, Kasaoka S, Saito T, Ishizawa S, Takemori S, Tazawa K, Tsukada K. Tumor regression by inductive hyperthermia combined with hepatic embolization using dextran magnetite-incorporated microspheres in rats. Int J Oncol 2000; 16: 1153–1158
   PubMed Web of Science ®Google Scholar
• DeNardo SJ, DeNardo GL, Miers LA, Natarajan A, Foreman AR, Gruettner C, Adamson GN, Ivkov R. Development of tumor targeting bioprobes ((111)In-chimeric L6 monoclonal antibody nanoparticles) for alternating magnetic field cancer therapy. Clin Cancer Res 2005; 11: S7087–7092
   PubMed Web of Science ®Google Scholar
• Goldberg SN, Gazelle GS, Mueller PR. Thermal ablation therapy for focal malignancy: A unified approach to underlying principles, techniques, and diagnostic imaging guidance. Am J Roentgenol 2000; 174: 323–331
   PubMed Web of Science ®Google Scholar
• Chinn SB, Lee FT, Jr, Kennedy GD, Chinn C, Johnson CD, Winter TC, III, Warner TF, Mahvi DM. Effect of vascular occlusion on radiofrequency ablation of the liver: Results in a porcine model. Am J Roentgenol 2001; 176: 789–795
   PubMed Web of Science ®Google Scholar
• Yamasaki T, Kurokawa F, Shirahashi H, Kusano N, Hironaka K, Okita K. Percutaneous radiofrequency ablation therapy for patients with hepatocellular carcinoma during occlusion of hepatic blood flow. Comparison with standard percutaneous radiofrequency ablation therapy. Cancer 2002; 95: 2353–2360
   PubMed Web of Science ®Google Scholar
• Ahmed M, Liu Z, Humphries S, Goldberg SN. Computer modelling of the combined effects of perfusion, electrical conductivity, and thermal conductivity on tissue heating patterns in radiofrequency tumour ablation. Int J Hyperthermia 2008; 24: 577–588
   PubMed Web of Science ®Google Scholar
• Pringle JH. Notes on the arrest of hepatic hemorrhage due to trauma. Ann Surg 1908; 48: 541–549
   PubMedGoogle Scholar
• Patterson EJ, Scudamore CH, Owen DA, Nagy AG, Buczkowski AK. Radiofrequency ablation of porcine liver in vivo: Effects of blood flow and treatment time on lesion size. Ann Surg 1998; 227: 559–565
   PubMed Web of Science ®Google Scholar
• Percivale A, Stella M, Barabino G, Pasqualini M, Pellicci R. Radiofrequency thermal ablation of hepatocellular carcinoma: Our five year experience. Ann Ital Chir 2004; 75: 635–642
   PubMedGoogle Scholar
• Takamatsu S, Matsui O, Gabata T, Kobayashi S, Okuda M, Ougi T, Ikehata Y, Nagano I, Nagae H. Selective induction hyperthermia following transcatheter arterial embolization with a mixture of nano-sized magnetic particles (ferucarbotran) and embolic materials: feasibility study in rabbits. Radiat Med 2008; 26: 179–187
   PubMedGoogle Scholar
• Reimer P, Balzer T. Ferucarbotran (Resovist): A new clinically approved RES-specific contrast agent for contrast-enhanced MRI of the liver: Properties, clinical development, and applications. Eur Radiol 2003; 13: 1266–1276
   PubMed Web of Science ®Google Scholar
• Enomoto T, Oda T, Aoyagi Y, Sugiura S, Nakajima M, Satake M, Noguchi M, Ohkohchi N. Consistent liver metastases in a rat model by portal injection of microencapsulated cancer cells. Cancer Res 2006; 66: 11131–11139
   PubMed Web of Science ®Google Scholar
• Iwamura T, Katsuki T, Ide K. Establishment and characterization of a human pancreatic cancer cell line (SUIT-2) producing carcinoembryonic antigen and carbohydrate antigen 19-9. Jpn J Cancer Res 1987; 78: 54–62
   PubMedGoogle Scholar
• Hashimoto S, Oda T, Yamada K, Takagi M, Enomoto T, Ohkohchi N, Takagi T, Kanamori T, Ikeda H, Yanagihara H, et al. The measurement of small magnetic signals from magnetic nanoparticles attached to the cell surface and surrounding living cells using a general-purpose SQUID magnetometer. Phys Med Biol 2009; 54: 2571–2583
   PubMed Web of Science ®Google Scholar
• Salloum M, Ma R, Zhu L. Enhancement in treatment planning for magnetic nanoparticle hyperthermia: Optimization of the heat absorption pattern. Int J Hyperthermia 2009; 25: 309–321
   PubMed Web of Science ®Google Scholar
• Ivkov R, DeNardo SJ, Daum W, Foreman AR, Goldstein RC, Nemkov VS, DeNardo GL. Application of high amplitude alternating magnetic fields for heat induction of nanoparticles localized in cancer. Clin Cancer Res 2005; 11: S7093–7103
   PubMed Web of Science ®Google Scholar
• Dewey WC. Arrhenius relationships from the molecule and cell to the clinic. Int J Hyperthermia 2009; 25: 3–20
   PubMed Web of Science ®Google Scholar
• Horng TL, Lin WL, Liauh CT, Shih TC. Effects of pulsatile blood flow in large vessels on thermal dose distribution during thermal therapy. Med Phys 2007; 34: 1312–1320
   PubMed Web of Science ®Google Scholar
• Rabin Y. Is intracellular hyperthermia superior to extracellular hyperthermia in the thermal sense?. Int J Hyperthermia 2002; 18: 194–202
   PubMed Web of Science ®Google Scholar
• Kalambur VS, Longmire EK, Bischof JC. Cellular level loading and heating of superparamagnetic iron oxide nanoparticles. Langmuir 2007; 23: 12329–12336
   PubMed Web of Science ®Google Scholar
• Keblinski P, Cahill DG, Bodapati A, Sullivan CR, Taton TA. Limits of localized heating by electromagnetically excited nanoparticles. J Appl Phys 2006; 100: 054305
   Web of Science ®Google Scholar
• Levy M, Wilhelm C, Siaugue J, Horner O, Bacri J, Gazeau F. Magnetically induced hyperthermia: Size-dependent heating power of γ-Fe2O3 nanoparticles. J Phys Condens Matter 2008; 20: 204133
   PubMed Web of Science ®Google Scholar
• International Commission on Non-Ionizing Radiation Protection. Guidelines for limiting exposure to time-varying electric, magnetic, and electromagnetic fields (up to 300 GHz). Health Phys 1998; 74: 494–522
   PubMed Web of Science ®Google Scholar
• Wang X, Gu H, Yang Z. The heating effect of magnetic fluids in an alternating magnetic field. J Magn Magn Materials 2005; 293: 334–340
   Web of Science ®Google Scholar
• Kita E, Yanagihara H, Hashimoto S, Yamada K, Oda T, Kishimoto M, Tasaki A. Hysteresis power-loss heating of ferromagnetic nanoparticles designed for magnetic thermoablation. IEEE Tran Magn 2008; 44: 4452–4455
   Web of Science ®Google Scholar
• Maeda H, Wu J, Sawa T, Matsumura Y, Hori K. Tumor vascular permeability and the EPR effect in macromolecular therapeutics: A review. J Control Release 2000; 65: 271–284
   PubMed Web of Science ®Google Scholar
• Matsumura Y, Maeda H. A new concept for macromolecular therapeutics in cancer chemotherapy: Mechanism of tumoritropic accumulation of proteins and the antitumor agent SMANCS. Cancer Res 1986; 46: 6387–6392
   PubMed Web of Science ®Google Scholar
• Kirpotin DB, Drummond DC, Shao Y, Shalaby MR, Hong K, Nielsen UB, Marks JD, Benz CC, Park JW. Antibody targeting of long-circulating lipidic nanoparticles does not increase tumor localization but does increase internalization in animal models. Cancer Res 2006; 66: 6732–6740
   PubMed Web of Science ®Google Scholar
• Chang IA, Nguyen UD. Thermal modeling of lesion growth with radiofrequency ablation devices. Biomed Eng Online 2004; 3: 27
   PubMed Web of Science ®Google Scholar